Pseudomonas aeruginosa utilizes the host-derived polyamine spermidine to facilitate antimicrobial tolerance

Chowdhury M Hasan1, Sian Pottenger1, Angharad E Green1

  • 1Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.

JCI Insight
|October 4, 2022
PubMed

Insights

Mutations in Pseudomonas aeruginosa that reduce antibiotic susceptibility in lab tests may not work in cystic fibrosis lungs. Host molecules like spermidine can protect bacteria, increasing resistance and biofilm formation.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Cystic Fibrosis Research

Background:

  • Pseudomonas aeruginosa diversifies during cystic fibrosis lung infections.
  • Loss-of-function mutations in pmrB were previously identified in P. aeruginosa from CF infections.
  • Understanding these bacterial adaptations requires complex model systems.

Purpose of the Study:

  • To investigate the in vivo impact of PmrB mutations on antibiotic susceptibility in Pseudomonas aeruginosa.
  • To explore the role of host factors in modulating bacterial response to antimicrobial pressure.

Main Methods:

  • Analysis of pmrB loss-of-function mutants in Pseudomonas aeruginosa.
  • In vitro minimum inhibitory concentration (MIC) testing for various antimicrobial classes.
  • In vivo infection models (mice) and analysis of bacterial adaptation.
  • Investigation of outer membrane modifications (LPS) and polyamine interactions (spermidine).

Main Results:

  • PmrB mutations decreased in vitro antibiotic susceptibility but this was not observed in vivo.
  • Loss of PmrB altered LPS, increasing outer membrane negative charge and cationic antimicrobial uptake.
  • Host-derived spermidine coated PmrB-deficient P. aeruginosa, reducing susceptibility and promoting biofilm formation.
  • Spermidine levels were elevated during P. aeruginosa infection and antimicrobial treatment in CF patients.

Conclusions:

  • In vitro findings on antibiotic resistance do not always translate to the in vivo cystic fibrosis lung environment.
  • Host-derived polyamines like spermidine can counteract bacterial mutations conferring antimicrobial resistance.
  • Studying bacterial adaptation in clinically relevant conditions is crucial for understanding antimicrobial resistance.